Focuses on Federal agency competition with private industry. ; Record is based on bibliographic data in CIS US Congressional Committee Hearings Index. Reuse except for individual research requires license from Congressional Information Service, Inc. ; Indexed in CIS US Congressional Committee Hearings Index Part VI ; Focuses on Federal agency competition with private industry. ; Mode of access: Internet.
Pt. 5--Continuation of hearings on FDA drug safety regulations and requirements. Focuses on approval of DMSO (dimethyl sulfoxide). ; Pt. 4--Continuation of hearing on controls over drugs that may be released for public consumption. Examines FDA role in monitoring pharmaceutical companies manufacturing practices. Focuses in part on case involving mixup of labels on a number of drugs produced by Abbott Laboratories of North Chicago, Ill. ; Pt. 3--Continuation of hearing on controls over drugs that may be released for public consumption. Examines FDA organization, policies and procedures for processing applications for testing investigational drugs. Focuses in part on the anti-depressant drug Parnate that was approved for sale but taken off the market. ; Pt. 2--Surveys VA and NIH drug safety research programs, and investigates FDA drug approval process for Flexin and Orabilex. ; Pt. 1--Surveys FDA, AMA, and pharmaceutical industry drug safety research and regulatory programs. ; Hearings held Mar. 9, 10, May 25, 26, June 7-9, 1966--pt. 5. ; Hearings held July 20, 22, 27, Aug. 3, 10, Sept. 24, 1965--pt. 4. ; Hearings held before the Eighty-eighth Congress, second session and other sessions of later Congresses. ; "Intergovernmental Relations Subcommittee'--Pt. 1, page 1. ; Pt. 5--Continuation of hearings on FDA drug safety regulations and requirements. Focuses on approval of DMSO (dimethyl sulfoxide). ; Pt. 4--Continuation of hearing on controls over drugs that may be released for public consumption. Examines FDA role in monitoring pharmaceutical companies manufacturing practices. Focuses in part on case involving mixup of labels on a number of drugs produced by Abbott Laboratories of North Chicago, Ill. ; Pt. 3--Continuation of hearing on controls over drugs that may be released for public consumption. Examines FDA organization, policies and procedures for processing applications for testing investigational drugs. Focuses in part on the anti-depressant drug Parnate that was approved for sale but taken off the market. ; Pt. 2--Surveys VA and NIH drug safety research programs, and investigates FDA drug approval process for Flexin and Orabilex. ; Pt. 1--Surveys FDA, AMA, and pharmaceutical industry drug safety research and regulatory programs. ; Hearings held Mar. 9, 10, May 25, 26, June 7-9, 1966--pt. 5. ; Hearings held July 20, 22, 27, Aug. 3, 10, Sept. 24, 1965--pt. 4. ; Mode of access: Internet.
"First issued October 1966 as Committee Print for use of Committee on Government Operations, U.S. House of Representatives, 89th Congress, 2d session. Reprinted with Revised Foreword, June 1967"--Page 2 of cover. ; "Prepared by Bernard J. Frieden for the Advisory Commission on Intergovernmental Relations." ; At head of title: Commission findings and proposals. ; Includes bibliographical references and index. ; Mode of access: Internet.
"[Prepared by Bernard J. Frieden] submitted to the Intergovernmental Relations Subcommittee of the Committee on Government Operations by the Advisory Commission on Intergovernmental Relations." ; At head of title: Committee print. 89th Congress, 2d session. House of Representatives. ; Mode of access: Internet.
Record is based on bibliographic data in CIS US Congressional Committee Hearings Index. Reuse except for individual research requires license from Congressional Information Service, Inc. ; Indexed in CIS US Congressional Committee Hearings Index Part VIII ; Mode of access: Internet.
Hearing was held in New York City. ; Record is based on bibliographic data in CIS US Congressional Committee Hearings Index. Reuse except for individual research requires license from Congressional Information Service, Inc. ; Indexed in CIS US Congressional Committee Hearings Index Part VII ; Hearing was held in New York City. ; Mode of access: Internet.
Reuse of record except for individual research requires license from Congressional Information Service, Inc. ; Hearings held Mar. 6-May 12, 1974. ; Hearings in part 2- held before the Committee's Intergovernmental Relations and Human Resources Subcommittee. ; CIS Microfiche Accession Numbers: CIS 75 H401-1, CIS 75 H401-27, CIS 76 H401-16 ; Includes bibliographical references. ; Microfiche. ; Mode of access: Internet.
Hearings held Mar. 6-May 21, 1974. ; Hearings in part 2- held before the Committee's Intergovernmental Relations and Human Resources Subcommittee. ; Includes bibliographical references. ; Mode of access: Internet.
